NewsRoom Articles - Page 574 of 587

ThursdayMay 18, 2017 11:49 am

India Globalization Capital, Inc. (NYSE: IGC) is Blazing a Trail with its Cannabis Plus Therapies

Slowly but surely cannabis is losing the stigma that has plagued it for close to one hundred years. Even some who frown on its use for recreational purposes are willing to consider that there may be therapeutic benefits in extracts of the cannabis sativa plant and so, increasingly, cannabinoids are being investigated to determine their effectiveness to treat a variety of debilitating medical conditions. Cannabinoid pharma is emerging as an entirely new industry segment in pharmaceuticals, and, as it does so, one innovative research company is blazing a trail in this new market by creating a niche of its own.…

WednesdayMay 17, 2017 9:00 am

Cannabis-Based Therapies with Potential to Dull the Pain of Opioid Abuse

CannabisNewsWire Editorial Coverage: America is in an opioid epidemic. On an average day, 91 Americans will die from an opioid-related overdose. That’s according to the CDC, which also reports that the number of prescription opioids sold in the U.S. has nearly quadrupled since 1999 despite no overall change in the amount of pain reported. The result is more than half a million deaths by opioid overdose from 2000 to 2015. These sobering figures reveal the desperate need for opioid substitutes, and cannabis-based therapies for pain treatment are emerging as viable alternatives. The potential rewards are significant for companies that can…

TuesdayMay 16, 2017 1:25 pm

SinglePoint (SING) Diversification Strategy Sets Stage for Big Rewards When Cannabis Industry Becomes Bankable

While some investors still view the marijuana market as a new industry, the mammoth potential of the cannabis industry — both in the United States and worldwide — cannot be discounted. While marijuana has not yet been legalized in the U.S. at the federal level, 29 states as well as the District of Columbia have, so far, passed laws or initiatives to legalize or regulate it, and the industry has been growing at an unexpectedly high rate. Some savvy companies are safeguarding against the risk of violating present federal laws by capitalizing on the growth of the cannabis industry in…

MondayMay 15, 2017 9:49 am

ChineseInvestors.com, Inc. (CIIX) Projected To Reach Revenue of $14.8 Million by FY2020 in Consilium Global Research Report

ChineseInvestors.com, Inc. (OTCQB: CIIX) is projected to reach revenues of $14.8 million by fiscal year 2020, according to a new research report by Consilium Global Research (http://nnw.fm/kKO7e). Per the report, the company did $930,000 in revenue for fiscal 2016 and is projected to grow at a compound annual growth rate (CAGR) of approximately 100% through 2020. The underlying market’s CAGR will expand at an 80% rate, the report said. Consilium sees CIIX as going through a huge transformation this year as it pursues a larger stake in the cannabis market. Headquartered in San Gabriel, California, CIIX offers a range of…

ThursdayMay 11, 2017 11:54 am

SinglePoint, Inc. (SING) Set to Capitalize on Payment Markets Opportunity in MMJ Industry after Congress Triggers Safe Harbor Protection

With the passage of the Rohrabacher-Farr amendment in the $1.1 trillion spending bill to fund the government until September 30, 2017, Congress continues its hands-off approach to the medical marijuana industry. Attached as a rider to the appropriations bill, Rohrabacher-Farr now allows marijuana dispensaries powerful ‘safe harbor’ protections. As a consequence, SinglePoint, Inc. (OTC: SING) is rebooting its initiatives, started two years ago, to be a ‘first mover’ in providing payment solutions to the cannabis vertical through its SingleSeed payments subsidiary. SinglePoint has been working with medical marijuana (MMJ) businesses for a long time, as GeekWire reported in August 2014…

WednesdayMay 10, 2017 9:00 am

Marijuana Stocks Drive Corporate Value by Delivering Automation, Technology and Diverse Application

CannabisNewsWire Editorial Coverage: The marijuana market is ripe with investment opportunities, and the leaders of the pack are those who demonstrate the vision and ability to increase corporate value. Be it through revolutionary technology, health applications, packaging and accessories, cultivation tools or other means, companies like SinglePoint, Inc. (SING) (SING Profile), Kush Bottles, Inc. (KSHB), Insys Therapeutics, Inc. (INSY), Solis Tek, Inc. (SLTK) and Medical Marijuana, Inc. (MJNA) are capturing their share of a burgeoning market and presenting investors with unique and exciting opportunities to climb aboard. In North America, the cannabis market was valued at approximately $7.2 billion in…

TuesdayMay 09, 2017 3:23 pm

ChineseInvestors.com, Inc. (CIIX) Aims to Excel in CBD Markets

For nearly two decades, ChineseInvestors.com (OTCQB: CIIX) has delivered a wide range of products, information, and services, including several subscription-based services, for the global Chinese speaking population. The specialized investment services company provides real-time market commentary, analysis, and education-related information in the Chinese language, as well as offering consultation, advertising, and public relations services. The company’s product diversity is a result of its growth-focused, long term quest for value-add opportunities. Not satisfied with a 100,000+ user base, a recognizable 18-year-old brand, and a target market in excess of two billion Chinese speaking people, ChineseInvestors.com recently executed a first-to-market milestone by…

MondayMay 08, 2017 2:55 pm

ABcann Medicinals (TSXV: ABCN) Has Strong Start with Canadian TSX Venture Exchange Listing

Going public appears to be paying off for ABcann Medicals (TSXV: ABCN), since the medical cannabis grower launched its initial public offering (IPO) on the TSX Venture Exchange. Although the IPO was just launched on May 4 (http://nnw.fm/Lt5DO), its value took off, soaring over 26% on the first day and trading over 25% of the total volume on the exchange. ABcann is one of Canada’s major legal cannabis producers, and the public offers are set to provide even more investor benefits as the recreational marijuana market is now positioned for nationwide legalization. Raising capital was part of the company’s decision…

MondayMay 08, 2017 12:55 pm

India Globalization Capital, Inc. (NYSE: IGC) Positioned to Lead in Phytocannabinoid Pharmaceuticals

A study recently highlighted by the American Epilepsy Society (AES) at its 70th annual meeting focused on the potential of cannabidiol (CBD), a derivative of the cannabis plant, as a promising treatment for reducing both the frequency and severity of seizures in children with drug resistant epilepsies (http://nnw.fm/u3xAh). According to the study, patients who received CBD treatment exhibited over 45 percent mean reduction in seizures, and researchers were outspoken in support of further research. Cannabidiol is the most abundant non-psychoactive cannabinoid found in the cannabis plant. Both anecdotal evidence and pre-clinical research have suggested that CBD may have a broad…

FridayMay 05, 2017 2:37 pm

India Globalization Capital, Inc. (NYSE: IGC) Engages a Critical Point in Cannabis History

Cannabis is now legal medically or recreationally in 28 states in the U.S., and companies such as India Globalization Capital, Inc. (NYSE MKT: IGC) are developing revolutionary cannabinoid-based combination pharmaceutical therapies. Cannabis’ history doesn’t begin in the 1960s. Scientists have dated burned cannabis seeds found in Siberia to 3,000 B.C., and mummified psychoactive marijuana has been found in tombs of individuals buried around 2,500 B.C. Fast forward a few thousand years and add laws, regulations, and cultural stigma, and behold one of the most disputed substances. In the 1850s, recreational cannabis was considered fashionable in the U.S., and it was…

News and publishing service for cannabis related companies

Contact us: 512.354.7000